Clusterin levels are up-regulated under conditions of cell stress and tissue injury and in patients suffering from myocardial infarction, dialyses-related amyloidosis, atherosclerosis, cancer, diabetes and neurodegenerative diseases [9]. This evidence concerns the gene CLU and atherosclerosis.